POM
POMDOCTOR LIMITED American Depositary SharesNASDAQ
Healthcare • Pharmaceutical Retailers
Updated 1 day ago
Coverage limited
$0.75+20.03%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- +5.0%
- 3 months
- -50.6%
- 1 year
- -99.0%
- Dividend
- No dividends on record
- Short interest
- 0.8% of float26K shares · settled Sep 30, 2026 · +42.1% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if POM is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: LOW
1 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
6 filers reported a long position in POM for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
Q1 2026 shares are adjusted for the 2026-06-22 1-for-18 reverse split.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| CITADEL ADVISORS LLC | $30.8K | 21.3K | New |
| UBS Group AG | $5K | 3.5K | New |
| Caitong International Asset Management Co., Ltd | $1.3K | 893 | New |
| Arax Advisory Partners | $1K | 722 | New |
| Steward Partners Investment Advisory, LLC | $161 | 111 | New |
| RHUMBLINE ADVISERS | $60 | 41 | New |
Get the Full Analysis for POM
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.